A Simple Approach to Increase Donor Hematopoeitic Stem Cell Dose and Improve Engraftment in the Murine Model of Allogeneic In Utero Hematopoietic Cell Transplantation.

The rationale for IUHCT rests upon exploitation of normal events during hematopoietic and immunologic ontogeny to allow allogeneic hematopoietic engraftment without myeloablative conditioning.  Host hematopoietic competition is among the primary barriers to engraftment in IUHCT. In the murine model, this can be partially overcome by delivery of larger donor cell doses, but volume is limiting. Enrichment of donor HSC would seem to offer a more efficient approach, but such enriched populations have engrafted poorly in existing models of IUHCT. To increase HSC dose while maintaining the presence of accessory cells, we we used a less stringent enrichment protocol of single step lineage depleted cells alone (Lin-) or in combination with whole donor bone marrow mononuclear cells. Our results confirm that increasing doses of HSC in combination with BM accessory cells can dramatically improve engraftment after IUHCT. This represents a practical and clinically applicable strategy to maximize the engraftment potential of the donor graft without risk of treatment-associated toxicity.